Mid-Link Group
Latest round
- Series B
Last raised
- Jul 2022
Total raised
- $30M
Investors
- 3
About Mid-Link Group
Established in 2005 and based in Tianjin, China, Mid-Link Group is a medical regulations consulting and testing comprehensive service provider that focus on medical device, drug preclinical testing, animal experimentation and registration regulatory consultation. The company founder Xiaoming Hong has 17 years experience in the field of medical device quality system and registration regulations consulting. Besides she is secretary general of China Medical Device Association and professor of Shanghai University. The company established service outlets in Beijing, Tianjin, Shanghai, Jinan, Suzhou, Shenzhen, Houston and Vancouver. The company's business covers product lifecycle services, service-based manufacturing, intelligent creation and third-party testing and certification. Mid-Link Group also provides biocompatibility testing, microbial testing, process validation and preclinical testing for customer.
Who invested in Mid-Link Group
3 investors across 2 rounds
See all investors in Mid-Link Group
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mid-Link Group
Who invested in Mid-Link Group?
Mid-Link Group has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mid-Link Group raised?
Mid-Link Group has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mid-Link Group last raise money?
Mid-Link Group's most recent round on record is a Series B, in Jul 2022.
What does Mid-Link Group do?
Established in 2005 and based in Tianjin, China, Mid-Link Group is a medical regulations consulting and testing comprehensive service provider that focus on medical device, drug preclinical testing, animal experimentation and registration regulatory consultation.
Where is Mid-Link Group headquartered?
Mid-Link Group is headquartered in Tianjin, China.
Which VCs invest in companies like Mid-Link Group?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Mid-Link Group's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Mid-Link Group? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.